We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
-0.57%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$19B
AUM Growth
+$1.28B
(+7.2%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
8.12%
Top 10 Holdings %
Top 10 Hldgs %
20.03%
Holding
3,992
New
448
Increased
1,821
Reduced
816
Closed
180
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elanco Animal Health
ELAN
|
+$89.1M |
| 2 |
WEX
WEX
|
+$78.4M |
| 3 |
Blackrock
BLK
|
+$73.2M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$71.9M |
| 5 |
OneMain Financial
OMF
|
+$45.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$63.6M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$56.6M |
| 3 |
Agnico Eagle Mines
AEM
|
+$55.1M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$36M |
| 5 |
ORBC
ORBCOMM, Inc.
ORBC
|
+$27.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.39% |
| 2 | Financials | 14.65% |
| 3 | Healthcare | 12.11% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ANSS
1401
DELISTED
Ansys
ANSS
| $337K | ﹤0.01% |
994
-387
| -28% | -$140K |
|
1402
iShares US Financials ETF
IYF
$4.61B
| $337K | ﹤0.01% |
4,088
-158
| -4% | -$13.1K |
|
1403
iShares Global Financials ETF
IXG
$687M
| $336K | ﹤0.01% |
4,286
+842
| +24% | +$66K |
|
1404
Enphase Energy
ENPH
$5.53B
| $335K | ﹤0.01% |
2,247
+172
| +8% | +$29.5K |
|
1405
Rithm Capital
RITM
$5.69B
| $335K | ﹤0.01% |
30,597
+239
| +0.8% | +$2.46K |
|
1406
GoodRx Holdings
GDRX
$1.26B
| $333K | ﹤0.01% |
8,142
+3,547
| +77% | +$129K |
|
|
AGD
1407
abrdn Global Dynamic Dividend Fund
AGD
$320M
| $332K | ﹤0.01% |
28,600
+14,100
| +97% | +$171K |
|
|
CLR
1408
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $332K | ﹤0.01% |
7,209
-189,948
| -96% | -$7.17M |
|
1409
Invitation Homes
INVH
$18B
| $330K | ﹤0.01% |
8,645
+2,061
| +31% | +$82.6K |
|
1410
Monster Beverage
MNST
$88.5B
| $330K | ﹤0.01% |
7,444
-51,000
| -87% | -$2.41M |
|
1411
Invesco Municipal Income Opportunities Trust
OIA
$292M
| $330K | ﹤0.01% |
41,597
| – | – |
|
1412
DigitalBridge
DBRG
$2.95B
| $326K | ﹤0.01% |
13,548
| – | – |
|
1413
Editas Medicine
EDIT
$442M
| $323K | ﹤0.01% |
7,893
+5,379
| +214% | +$295K |
|
1414
Moelis & Co
MC
$4.94B
| $321K | ﹤0.01% |
5,194
+97
| +2% | +$5.81K |
|
1415
Oneok
OKE
$54.5B
| $321K | ﹤0.01% |
5,538
+2,248
| +68% | +$121K |
|
|
STOR
1416
DELISTED
STORE Capital Corporation
STOR
| $321K | ﹤0.01% |
10,056
+1,570
| +19% | +$55.6K |
|
1417
iPath Select MLP ETN
ATMP
$621M
| $320K | ﹤0.01% |
20,340
| – | – |
|
1418
Fox Class A
FOXA
$26.9B
| $320K | ﹤0.01% |
7,988
+1,484
| +23% | +$54.6K |
|
1419
Lemonade
LMND
$4.1B
| $320K | ﹤0.01% |
4,776
+1,200
| +34% | +$96.7K |
|
|
MOMO
1420
Hello Group
MOMO
$866M
| $319K | ﹤0.01% |
30,160
-1,214
| -4% | -$15.2K |
|
1421
ProShares Online Retail ETF
ONLN
$66.8M
| $319K | ﹤0.01% |
4,868
-864
| -15% | -$63K |
|
|
PSTH
1422
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
| $319K | ﹤0.01% |
16,198
+200
| +1% | +$4.05K |
|
1423
Booz Allen Hamilton
BAH
$9.15B
| $318K | ﹤0.01% |
4,016
+461
| +13% | +$38.5K |
|
1424
Digital Turbine
APPS
$1.74B
| $317K | ﹤0.01% |
4,628
-1,879
| -29% | -$117K |
|
1425
Crown Holdings
CCK
$13.1B
| $317K | ﹤0.01% |
3,153
+1,490
| +90% | +$156K |
|
Similar funds
NAMI
Rockefeller Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Rockefeller Capital Management held 3,992 positions worth $19B, up 7.2% from $17.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Rockefeller Capital Management deployed $1.55B of net new capital in Q3 2021, opening 448 new positions and adding to 1,821 existing holdings. Its largest new stake was Darling Ingredients: 56,725 shares worth $4.08M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $63.6M trimmed.
- Rockefeller Capital Management's largest Q3 2021 buy was Darling Ingredients: 56,725 shares worth $4.08M.
- Rockefeller Capital Management added most to Elanco Animal Health in Q3 2021, an estimated $89.1M increase.
- Rockefeller Capital Management's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $63.6M.
- Rockefeller Capital Management fully exited ORBCOMM, Inc. in Q3 2021, selling an estimated $27.5M.
- Rockefeller Capital Management's ten largest holdings make up 20% of its $19B portfolio in Q3 2021.
- Rockefeller Capital Management opened 448 new positions and closed 180 in Q3 2021.
- Rockefeller Capital Management's portfolio value rose 7.2% quarter-over-quarter to $19B.
Based on Rockefeller Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.